Lieve Heylen

The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound

Michel R. Briejer, Jean-Paul Bosmans, Paul Van Daele et al. · European Journal of Pharmacology · 2001 · 145 citations · Full text

Novel Enterokinetic Compound, Pharmacological Study, Biochemistry +6

Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.

J.E. Leysen, W Gommeren, Lieve Heylen et al. · Molecular Pharmacology · 1996 · 91 citations

Synthesis and biodistribution of [11C]R107474, a new radiolabeled α2-adrenoceptor antagonist

Margreet van der Mey, Albert D. Windhorst, R. Klok et al. · Bioorganic & Medicinal Chemistry · 2006 · 45 citations

Molecular Pharmacology, Adrenal Gland, Biochemistry +5

Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5‐HT_1B and 5‐HT_1D receptors expressed in various mammalian cell lines

Anne Lesage, Ria Wouters, Paul Van Gompel et al. · British Journal of Pharmacology · 1998 · 41 citations · Full text

Pharmacological Profile of (2 R-trans)-4-[1-[3,5-bis(Trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an Orally and Centrally Active Neurokinin-1 Receptor Antagonist

Anton A. H. P. Megens, D. Ashton, Jef Vermeire et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 26 citations